CLOs on the Move


 
Eledon Pharmaceuticals, Inc. is a clinical stage biotechnology company using its expertise in targeting the CD40L pathway to develop potential treatments for people undergoing organ or cellular transplantation, and for people with autoimmune and neurodegenerative disease. Our lead program, AT-1501, is a potential best-in-class humanized IgG1 anti-CD40L antibody with high affinity for CD40L, a well-validated biological target with broad therapeutic potential. The CD40/CD40L pathway plays a central role in generating pro-inflammatory responses in autoimmune disease, allograft transplant rejection, and neuroinflammation.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.eledon.com
  • 19900 MacArthur Boulevard Suite 550
    Irvine, CA USA 92612
  • Phone: 949.238.8090

Executives

Name Title Contact Details
David Hovland
Chief Regulatory Officer Profile
Bryan Smith
General Counsel, Corporate Secretary, and Chief Compliance Officer Profile

Similar Companies

Catalyst Pharmaceuticals

Catalyst Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating diseases, including Lambert-Eaton myasthenic syndrome (LEMS), congenital myasthenic syndromes (CMS), infantile spasms, and Tourette`s Disorder.

Gerigene Medical Corporation

Gerigene Medical Corporation is a Madison, WI-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Nulixir

Nulixir is a B2B nanobiotechnology company that develops, manufactures, and licenses intellectual property for smart nanocarriers, called nanovesicles, which optimize the performance of functional ingredients in food & beverage products.

PHC Holdings

This is the website of PHC Holdings Corporation, which is a global innovator in healthcare solutions.

Zitomer Pharmacy Inc

Zitomer Pharmacy Inc is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.